Professor Petter Brodin joins Imperial as Garfield Weston Chair of Neonatology
Petter Brodin has been appointed as the Garfield Weston Chair of Neonatology and Professor of Paediatric Immunology at Imperial College London.
Feature
A life in paediatric HIV research and care: Prof Gareth Tudor-Williams retires
Professor Gareth Tudor-Williams has retired after a career spanning over three decades in paediatric HIV research and care.
New vaccine study to investigate durability of COVID-19 immunity
UK Research and Innovation (UKRI) funding will support new research into the durability of COVID-19 immunity after vaccination and natural infection.
Histamine could be a key player in depression, according to study in mice
Bodily inflammation dampens levels of a ‘feel-good molecule’ and antidepressants’ ability to boost them, according to new research in mice.
4
Third mRNA COVID vaccine dose could benefit immunocompromised dialysis patients
People who attend hospital for their dialysis treatment (haemodialysis) could benefit from an early third dose of an mRNA COVID-19 vaccine.
Blood clots in severe COVID cases may be related to abnormal antibody response
Inflammation and blood clotting seen in severe cases of COVID-19 may be caused by antibodies activating unnecessary platelet activity in the lungs.
New study sheds light on link between joint injury and osteoarthritis
Researchers investigated the factors underlying the association between acute knee injury and osteoarthritis, the most prevalent form of arthritis.
Feature
Long COVID: Unpicking the lasting impact of COVID-19
Poorly defined and understood, the far-reaching impact of long COVID is emerging as the next battleground of the COVID-19 pandemic.
First major study of new HIV therapy opens to recruitment
The RIO clinical trial will test whether a new type of therapy can keep HIV under control without daily antiretroviral treatment (ART) tablets.
Key enzyme aggravates colorectal cancer in obese patients
New research suggests the enzyme CES1 helps tumour cells to survive and drives aggressive colorectal cancer in obese patients.
